Gary Ingenito is Chief Med. & Reg. Officer at CATALYST PHARMACEUTICALS, INC. (CPRX). They have made 15 open-market trades across 1 company since 2019, most recently 2025-05-14.
CIK 0001279473
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CPRX | 268,873 | $8.5M |
Shares reported on the most recent Form 4, priced at the 2025-05-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPRX | SELL | 2025-05-13 | 2025-05-15 | $23.67 | $5.8M | +4.8% | +1.0% | -13.8% |
| CPRX | SELL | 2025-03-05 | 2025-03-07 | $21.75 | $9.8M | +5.0% | +1.3% | +17.8% |
| CPRX | SELL | 2024-11-27 | 2024-11-29 | $22.72 | $545K | -0.6% | -4.7% | -2.0% |
| CPRX | SELL | 2024-11-20 | 2024-11-22 | $21.20 | $806K | +0.9% | +0.5% | +2.6% |
| CPRX | SELL | 2024-08-09 | 2024-08-13 | $18.04 | $1.8M | +3.8% | +3.6% | +19.8% |
| CPRX | SELL | 2024-06-05 | 2024-06-07 | $16.16 | $1.3M | -0.6% | +1.2% | +29.8% |
| CPRX | SELL | 2023-12-06 | 2023-12-08 | $14.02 | $701K | +1.3% | +7.1% | +17.9% |
| CPRX | SELL | 2022-12-06 | 2022-12-08 | $16.85 | $199K | +11.0% | +13.5% | -8.5% |
| CPRX | SELL | 2022-09-14 | 2022-09-16 | $15.67 | $2.2M | -2.0% | +0.4% | +29.4% |
| CPRX | SELL | 2022-06-21 | 2022-06-23 | $6.60 | $1.9M | +11.1% | +47.2% | +84.9% |
| CPRX | SELL | 2021-12-07 | 2021-12-08 | $6.99 | $25K | +0.6% | -4.7% | +8.7% |
| CPRX | SELL | 2020-12-22 | 2020-12-28 | $3.45 | $13K | +0.9% | +5.2% | +22.3% |
| CPRX | SELL | 2019-12-05 | 2019-12-06 | $4.82 | $723K | -10.6% | -10.4% | -10.2% |
| CPRX | SELL | 2019-11-27 | 2019-11-27 | $4.66 | $466K | -1.7% | -19.0% | -2.4% |
| CPRX | SELL | 2019-11-21 | 2019-11-22 | $4.50 | $450K | +4.9% | -14.0% | +16.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.